Found 72 matching trials
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) PHASE1 The goal of this clinical trial is to investigate the utility of biomarker ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients N/A To evaluate the potential usefulness of 68Ga/18F-PD-L1 positron emission to...
Show More Location
The First Affiliated Hospital of University of Science and Technology of China
Learn More & Join Trial
PD-L1 PET-imaging During CAR T-cell Therapy PHASE2 This is a single-center, single-arm pilot trial designed to evaluate the ex...
Show More Status
Active Not Recruiting
Location
University Medical Center Groningen
Learn More & Join Trial
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction PHASE1 Safety and tolerability of neoadjuvant nivolumab for locally advanced resec...
Show More Location
VU University medical center
Learn More & Join Trial
CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk PHASE2 The purpose of this study is to evaluate the safety and feasibility of a tr...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
PD-L1 Expression in Cancer (PECan Study). NA Measurement of PD-L1 expression in cancer to monitor treatment response.
A...
Show More Location
Guy's and St Thomas' NHS Foundation Trust
Learn More & Join Trial
PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC PHASE1 Non-invasive imaging of tumor PD-L1 expression with 89Zr-labeled durvalumab...
Show More Learn More & Join Trial
Research for the Molecular Imaging of the PD-L1 Targeting Tracer NA To use the molecular probe PET radionuclide (Ga-68 or F-18) WL12 peptide to...
Show More Learn More & Join Trial
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This is an open-label, multicentre, randomised phase II trial in relapsed o...
Show More Status
Active Not Recruiting
Location
The Beatson West of Scotland Cancer Centre
Learn More & Join Trial
Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 PHASE2 This phase II trial studies how well fluorine F 18 Ara-G positron emission ...
Show More Location
University of California, San Francisco
Learn More & Join Trial